Clarity Pharmaceuticals Ltd (OTCPK:CLRPF) Stock News, Headlines & Updates
Clarity Pharmaceuticals Ltd Stock News from GuruFocus
- 1
Jul 17, 2025
Co-PSMA trial: Recruitment successfully completed
PRNewswire • 9:00am
Jun 17, 2025
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
PRNewswire • 9:00am
Jun 13, 2025
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
PRNewswire • 9:00am
Jun 05, 2025
DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.
PRNewswire • 9:00am
May 29, 2025
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT
PRNewswire • 9:00am
May 20, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news